Author:
Morgans A K,Fan K-H,Koyama T,Albertsen P C,Goodman M,Hamilton A S,Hoffman R M,Stanford J L,Stroup A M,Penson D F
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference25 articles.
1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF et al. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute: Bethesda, MD, USA. 2013. Available at:
http://seer.cancer.gov/csr/1975_2010/
(last accessed 23 July 2013).
2. Smith MR . Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diabetes Obes 2007; 14: 247–254.
3. Shahinian VB, Kuo Y, Freeman JL, Goodwin JS . Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352: 154–164.
4. Seeman E . The structural basis of bone fragility in men. Bone 1999; 25: 143–147.
5. Berruti A, Dogliotti L, Terrone C, Cerutti S, Isaia G, Tarabuzzi R et al. Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 2002; 167: 2361–2367.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献